Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 22, 2016

View Archived Issues

NYMC and Interprotein collaborate on C2 domain-interactive therapeutics

Theranexus obtains funding for development of THN-201

Bayer and Evotec establish 5-year research partnership in kidney disease

Regen BioPharma's NR2F6 modulators show positive preclinical results

Abilita Bio awarded grant from NCI

Takeda and Affilogic establish Nanofitins research collaboration for neurological disorders

NuSirt and OWL Metabolomics partner to develop companion diagnostic for NS-0200

Chromosome 1 variant is associated with increased risk of IFN-beta-induced liver injury

NIH award supports Symbiotix's development of PSA for IBD

Novel model for the development of phages that target pathogenic bacteria

Artios Pharma launched to focus on developing novel DNA damage response cancer therapies

Allergan acquires Akarna Therapeutics

AstraZeneca withdraws MAA for cediranib

Aurigene Discovery Technologies patents PD-1 signaling inhibitors

Sunshine Lake Pharma discloses HCV inhibitors

Eleven Biotherapeutics acquires Viventia Bio

Nanjing Sanhome Pharmaceutical describes PI3Kdelta inhibitors

Medshine Discovery develops CDK4/cyclin D1 and CDK6/cyclin D1 inhibitors

Melinta Therapeutics presents antibacterials

Quest Diagnostics launches Zika antibody test service

EMA grants PRIME scheme access to Bluebird's Lentiglobin and Juno's JCAR-015

Newron re-submits Xadago NDA

Regulus begins phase II trial of RG-012 in Alport syndrome

Takeda presents phase II results for TAK-448 in men with T2D and HH

Kadmon initiates phase II trials of KD-025 in psoriasis and GvHD

FDA approves Janssen Pharmaceuticals' Invokamet XR

Gilead stops phase II/III study of GS-5745 in ulcerative colitis based on DMC review

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...